Mycophenolate mofetil in autoimmune and inflammatory skin disorders

Journal of the American Academy of Dermatology

Volumn 40, Issue 2 I, 1999, Pages 265-268

  Nousari, H C ^a   Sragovich, A ^a   Kimyai Asadi, A ^a   Orlinsky, D ^a   Anhalt, G J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; ETRETIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THALIDOMIDE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PEMPHIGOID; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION;

EID: 0032966991     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70203-3     Document Type: Article

References (19)

1. AH Enk J Knop Treatment of pemphigus vulgaris with mycophenolate mofetil [letter] Lancet 350 1997 494
2. M Bohm S Beisert T Shwarz Bullous pemphigoid treated with mycophenolate mofetil [letter] Lancet 349 1997 541
3. HC Nousari WA Griffin GJ Anhalt Successful therapy of bullous pemphigoid with mycophenolate mofetil J Am Acad Dermatol 39 1998 497 498
4. U Hohenleutner VD Mohr S Michel M Landthaler Mycophenolate mofetil and cyclosporine treatment for recalcitrant pyoderma gangrenosum [letter] Lancet 350 1997 1748
5. Nousari HC, Lynch W, Petri M, Anhalt GJ. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol In press.
6. MG Haufs S Beissert S Grabbe B Schutte TA Luger Psoriasis vulgaris treated successfully with mycophenolate mofetil Br J Dermatol 138 1998 179 181
7. A Picknacker TA Luger T Schwarz Dyshidrotic eczema treated with mycophenolate mofetil Arch Dermatol 134 1998 378 379
8. JJ Lipsky Mycophenolate mofetil Lancet 348 1996 1357 1359
9. JE Silverman Kitchin M Keltz Pomeranz G Pak Rediscovering mycophenolic acid: review article of its mechanism, side effects, and potential use J Am Acad Dermatol 37 1997 445 449
10. R Nowack R Birck FJ van der Woude Mycophenolate mofetil for systemic vasculitis and IgA nephropathy [letter] Lancet 349 1997 774
11. A Gavlik MG Goldberg A Tsaroucha Mycophenolate mofetil rescue therapy in liver transplant recipients Transplantation Proc 29 1997 549 552
12. DO Taylor The use of tacrolimus and mycophenolate mofetil after cardiac transplantation Curr Opin Cardiol 12 1997 161 165
13. B Zimmer-Molsberger W Knauf E Thiel Mycophenolate mofetil for severe autoimmune haemolytic anemia Lancet 350 1997 1003 1004
14. WW Epinette CM Parker EL Jones MC Greist Mycophenolic acid for psoriasis: a review of pharmacology, long-term efficacy, and safety J Am Acad Dermatol 17 1987 962 971
15. European Mycophenolate Mofetil Cooperative Study Group Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection Lancet 345 1995 1321 1325
16. HW Solinger US Renal Transplant Mycophenolate Mofetil Study Group Mycophenolate mofetil for the prevention of acute rejection in cadaveric renal allograft recipients Transplantation 60 1995 225 232
17. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation 61 1996 1029 1037
18. A Greismacher G Weigel G Seebacher MM Muller IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide Clin Chem 43 1997 2312 2317
19. B Kaplan SA Gruber R Nallamathou SM Katz LM Shaw Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure Transplantation 65 1998 1127 1129